¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"positive conversion"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • automatic intermittent positive pressure respirator
    ÀÚµ¿°£Çæ¾ç¾ÐÈ£Èí±â
  • biologic false positive reaction
    »ý¹°ÇÐÀû°ÅÁþ¾ç¼º¹ÝÀÀ
  • continuous positive airway pressure
    Áö¼Ó±âµµ¾ç¾Ð
  • continuous positive pressure breathing
    Áö¼Ó¼º¾ç¾ÐÈ£Èí(¹ý)
  • chromatin-positive
    ¿°»öÁú¾ç¼º-
  • false positive
    °ÅÁþ¾ç¼º, °¡¾ç¼º
  • false positive reaction
    °ÅÁþ¾ç¼º¹ÝÀÀ, °¡¾ç¼º¹ÝÀÀ
  • gram-positive
    ±×¶÷¾ç¼º-
  • gram-positive bacterium
    ±×¶÷¾ç¼º±Õ
  • intermittent positive pressure breathing
    °£Çæ¾ç¾ÐÈ£Èí
  • intermittent positive pressure ventilation
    °£Çæ¾ç¾Ðȯ±â(¹ý)
  • positive
    1. ¾ç¼º- 2. ±àÁ¤-
  • positive acceleration
    ¾ç¼º°¡¼Óµµ
  • positive afterimage
    ¾ç¼ºÀÜ»ó
  • positive convergence
    ¾ç¼º´«¸ðÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • phage conversion
    ÆÄÁöÀüȯ, ÆÄÁö±³È¯
  • direct conversion x-ray detector
    Á÷Á¢Àüȯ¿¢½º¼±°ËÃâ±â, Á÷Á¢º¯È¯¿¢½º¼±°ËÃâ±â
  • egg negative conversion rate
    Ãæ¶õÀ½ÀüÀ²
  • roentgen-to-rad conversion factor
    ·ÛÆ®°Õ¶óµåº¯È¯°è¼ö
  • automatic intermittent positive pressure
    ÀÚµ¿°£Çæ¾ç¾ÐÈ£Èí±â
  • automatic intermittent positive pressure respirator
    ÀÚµ¿°£Çæ¾ç¾ÐÈ£Èí±â
  • positive acceleration
    ¾ç¼º°¡¼Ó
  • positive afterimage
    ¾ç¼ºÀÜ»ó
  • biologic false positive reaction
    »ý¹°ÇÐÀû°ÅÁþ¾ç¼º¹ÝÀÀ
  • continuous positive pressure breathing
    Áö¼Ó¼º¾ç¾ÐÈ£Èí(¹ý)
  • Gram-positive bacterium
    ±×¶÷¾ç¼º±Õ
  • intermittent positive pressure breathing
    °£Çæ¾ç¾ÐÈ£Èí
  • positive pressure breathing
    ¾ç¾ÐÈ£Èí(¹ý)
  • continuous positive airway pressure
    Áö¼Ó¼º±âµµ¾ç¾Ð
  • positive convergence
    ¾ç¼º´«¸ðÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • IPPB=£¾intermittent positive pressure breathing
    °£ÇæÀû ¾ç¾ÐÈ£Èí.
  • PANSS=Positive and Negative Syndrome Scale
    ¾ç¼º À½¼º ÁõÈıº ôµµ
  • PEEP(positive end-expiratory pressure)
    È£±â¸» ¾ç¾ÐÈ£Èí
  • Rh positive
    Rh ¾ç¼º
  • SAPS, Scale for the Assessment of Positive Symptoms
    ¾ç¼ºÁõ»óÆò°¡Ã´µµ
  • gram positive organism
    ±×·¥¾ç¼º¼¼±Õ.
  • hallucination, positive
    ¾ç¼ºÈ¯°¢(åÕàõü³ÊÆ)
  • high frequency positive pressure ventilation =HFPPV
    °íºóµµ¾ç¾Ðȯ±â.
  • positive acceleration
    ¾ç°¡¼Óµµ(Çö»ó)(åÕÊ¥áÜöôúÞßÚ).
  • positive after image
    ¾ç¼ºÀÜ»ó(åÕàõíÑßÀ).
  • positive after potential
    ¾ç¼ºÈÄÀüÀ§(åÕàõý­ï³êÈ).
  • positive afterimage
    ¾ç¼ºÀÜ»ó
  • positive airway pressure
    ±âµµ¾ç¾Ð(ѨԳ åÕäâ).
  • positive balance
    ¾ç¼º¼öÁö.
  • positive charge
    ¾çÀüÇÏ(åÕï³ùÃ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • dose conversion factor
    ¼±·®º¯È¯°è¼ö
  • gene conversion
    À¯ÀüÀÚº¯È¯(ܨüµ).
  • gene conversion
    À¯ÀüÀÚÀüȯ.
  • gene conversion
    À¯ÀüÀÚÀüȯ
  • gene conversion
    À¯ÀüÀÚÀüȯ
  • gene conversion
    À¯ÀüÀÚº¯È¯.
  • hysterical conversion
    ÀüȯÈ÷½ºÅ׸®,È÷½ºÅ׸®Àüȯ(¡­ï®üµ)
  • internal conversion
    ³»ºÎº¯È¯
  • lysogenic conversion
    ¿ë¿ø¼º º¯È¯.
  • lysogenic conversion
    ¿ë¿ø¼º º¯È¯.
  • lysogenic conversion
    ¿ë¿ø º¯È¯.
  • nipple,congenital conversion
    ¼±Ãµ¼º Àüȯ(à»ô¸àõ ï®üµ)
  • phage conversion
    ÆÄÁö±³È¯(¡­Îßüµ).
  • phage conversion
    ÆÄÁö±³È¯(¡­Îßüµ).
  • roentgen-to-rad conversion factor
    ·ÛÆ®°Õ¶óµåº¯È¯°è¼ö
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • conversion
    Àüȯ(ï®üµ)
  • conversion coefficient
    Àüȯ°è¼ö(ï®üµÌõâ¦)
  • conversion electron
    ÀüȯÀüÀÚ(ï®üµï³í­)
  • conversion factor
    ÀüȯÀÎÀÚ(ï®üµì×í­)
  • conversion period
    Àüȯ±â°£(ï®üµÑ¢Êà)
  • conversion stage
    Àüȯ½Ã±â(ï®üµãÁÑ¢)
  • gene conversion
    À¯ÀüÀÚ Àüȯ(ë¶îîí­ï®üµ)
  • internal conversion
    ³»ºÎÀüȯ(Үݻï®üµ)
  • internal conversion electron
    ³»ºÎÀüȯ ÀüÀÚ(Үݻï®üµï³í­)
  • lysogenic conversion
    ¿ë¿øº¯È¯(éÁê«Ü¨üµ)
  • phage conversion
    "ÆäÀÌÁö Àüȯ(ï®üµ), ÆäÀÌÁö º¯È¯(ܨüµ)"
  • precursor of serum prothrombin conversion accelerator
    Ç÷û(úìôè)ÇÁ·ÎÆ®·Òºó Àüȯ°¡¼ÓÁ¦ Àü±¸¹°Áú(ï®üµÊ¥áÜð¥îñÏÌÚªòõ)
  • prophage-mediated conversion
    ÇÁ·ÎÆäÀÌÁö ¸Å°³ Àüȯ(ØÚË¿ï®üµ)
  • serum prothrombin conversion accelerator
    Ç÷û(úìôè) ÇÁ·ÎÆ®·Òºó ÀüȯÃËÁøÁ¦(ï®üµõµòäð¥)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CC calcaneal-cuboid; calcium cyclamate; cardiac catheterization; cardiac contusion; cardiac cycle; card...
CR calculation rate; calculus removed; calorie-restricted; cardiac rehabilitation; cardiac resuscitatio...
DC daily census; data communication; data conversion; decrease; deep compartment; Dental Corps; deoxych...
DCF 2'-deoxycoformycin; dichlorofluorescin; direct centrifugal flotation; dopachrome conversion factor
DCR dacryocystorhinostomy; data conversion receiver; direct cortical response
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
FC Feed conversion
FCR Feed conversion ratio
FCR Food conversion ratio
auto-PEEP Auto-positive end expiratory pressure
BiPAP Bi-level positive airway pressure
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • positive airway pressure
    ±âµµ ¾ç¾Ð
  • positive aspect
    ÁÁÀº Ãø¸é
  • positive behavior
    ±àÁ¤ÀûÀΠŵµ
  • positive charge
    ¾ç ÀüÇÏ
  • positive communication
    ±àÁ¤ÀûÀÎ ´ëÈ­
  • positive convergence
    ¾ç¼º ´«¸ðÀ½, ¾ç¼º ÆøÁÖ
  • positive declination
    ¿Üȸ¼±
  • positive feedback loop
    ¾ç¼º µÇ¸ÔÀÌ±â °í¸®, ¾ç¼º Çǵå¹é °í¸®
  • positive habit history
    ¾ç¼ºÀÇ ½À°ü º´·Â
  • positive jump sign
    ¸í¹éÇÑ µµ¾à Çö»ó
  • positive modeling
    ±àÁ¤ÀûÀÎ º»º¸±â
  • positive occlusal awareness
    °úµµÇÑ ±³ÇÕ ÀνÄ
  • positive pole
    ¾ç±Ø
  • positive pressure
    ¾ç¾Ð, Á¤¾Ð
  • positive reinforcement
    ±àÁ¤Àû °­È­, ±àÁ¤Àû °­È­¹ý, ¾ç¼º °­È­
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
steam conversion factors (approximations) 1 pound of steam = 1,000 Btu = .3 kW. 10,000 lbs/hr steam = 300 boiler horsepower.
(05 Dec 1998)
internal conversion electron An electron, similar to an Auger electron, released from one of the electron orbits of the atom upon activation by a gamma-ray from that atom's nucleus; the electron has kinetic energy equal to the net energy transition of the disintegration.
(05 Mar 2000)
thermal conversion cycle <radiobiology> Process of generating electrical power with a fusion reactor by means of a steam / other gas turbine. This is distinct from direct conversion cycles.
(09 Oct 1997)
thermochemical conversion process Chemical reactions employing heat to produce fuels.
(05 Dec 1998)
fibrinogen-fibrin conversion syndrome <syndrome> A syndrome characterised by hypofibrinogenaemia with incoagulable blood; it may be seen in abruptio placentae, prolonged retention of a dead foetus in an Rh-isosensitised mother, haemolytic blood reactions, bilateral renal cortical necrosis, and cases of trauma.
(05 Mar 2000)
lysogenic conversion <virology> The ability of some phages to survive in a bacterium as a result of the integration of their DNA into the host chromosome. The integrated DNA is termed a prophage. A regulator gene produces a repressor protein that suppresses the lytic activity of the phage, but various environmental factors, such as ultraviolet irradiation may prevent synthesis of the repressor, leading to normal phage development and lysis of the bacterium. The best example of this is bacteriophage lambda.
(18 Nov 1997)
CD4-positive T-lymphocytes A critical subpopulation of regulatory T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the t4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes, which includes both the helper-inducer (T-lymphocytes, helper-inducer) and suppressor-inducer (T-lymphocytes, suppressor-inducer) T-cells.
(12 Dec 1998)
CD8-positive T-lymphocytes A critical subpopulation of regulatory T-lymphocytes involved in MHC class I-restricted interactions. They include both cytotoxic T-lymphocytes (T-lymphocytes, cytotoxic) and suppressor T-lymphocytes (T-lymphocytes, suppressor-effector).
(12 Dec 1998)
gram-positive <microbiology> Bacteria that retain the stain or that are resistant to decolourisation by alcohol during Gram's method of staining.
This is a primary characteristic of bacteria whose cell wall is composed of a thick layer of peptidologlycan containing teichoic and lipoteichoic acid complexed to the peptidoglycan.
See: gram-negative
(06 Oct 1997)
gram-positive asporogenous rods <microbiology> A gram-positive, non-spore-forming group of bacteria comprising organisms that have morphological and physiological characteristics in common.
(12 Dec 1998)
gram-positive asporogenous rods, irregular <microbiology> A group of irregular rod-shaped bacteria that stain gram-positive and do not produce endospores.
(12 Dec 1998)
gram-positive asporogenous rods, regular <microbiology> A group of regular rod-shaped bacteria that stain gram-positive and do not produce endospores.
(12 Dec 1998)
gram-positive bacteria <microbiology> Bacteria which retain the crystal violet stain when treated by gram's method.
(12 Dec 1998)
gram-positive bacterial infections <microbiology> Infections caused by bacteria that retain the crystal violet stain (positive) when treated by the gram-staining method.
(12 Dec 1998)
gram-positive cocci <microbiology> Coccus-shaped bacteria that retain the crystal violet stain when treated by gram's method.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • positive euthanasis
    Àû±ØÀû ¾È¶ô»ç
  • positive growth
    Ç÷¯½º ¼ºÀå
  • positive ion
    ¾çÀÌ¿Â
  • positive law
    ½ÇÁ¤¹ý
  • positive lens
    Á¤·»Áî
  • positive number
    ¾ç¼ö
  • positive organ
    ½Ç³» ¿À¸£°£
  • positive philosophy
    ½ÇÁõ öÇÐ
  • positive plate
    ¾ç±ØÆÇ
  • positive pole
    ºÏ±Ø;¾ç±Ø
  • positive proof
    È®Áõ
  • positive ray
    ¾ç±Ø¼±
  • positive sign
    Ç÷¯½º ±âÈ£
  • positive term
    ½Ç¸í»ç
  • positive virtue
    Àû±ØÀû ¹Ì´ö;½ÇÇàÀ¸·Î ³ªÅ¸³»´Â ´ö !
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á